Table 1.
Characteristics of patients
| ACT (−) (n=42) | ACT (+) (n=36) | p | Total (n=78) | |
|---|---|---|---|---|
|
| ||||
| Age (median) | 64–93 (81) | 54–77 (72) | <0.0001 | 54–93 (76) |
|
| ||||
| Sex (%) | ||||
| Male | 18 (42.9) | 23 (63.9) | 0.0637 | 41 (52.6) |
| Female | 24 (57.1) | 13 (36.1) | 37 (47.4) | |
|
| ||||
| Site of tumor (%) | ||||
| Renal pelvis | 20 (47.6) | 14 (38.9) | 0.4383 | 34 (43.6) |
| Ureter | 22 (52.4) | 22 (61.1) | 44 (56.4) | |
|
| ||||
| pT stage (%) | ||||
| 2 | 0 (0) | 1 (2.8) | 0.2770 | 1 (1.3) |
| 3 | 39 (92.9) | 34 (94.4) | 73 (93.6) | |
| 4 | 3 (7.2) | 1 (2.8) | 0.3836 | 4 (5.1) |
|
| ||||
| pN stage (%) | ||||
| Negative | 21 (50.0) | 20 (55.6) | 0.6242 | 41 (52.6) |
| Positive | 7 (16.7) | 10 (27.8) | 17 (21.8) | |
| Unknown | 14 (33.3) | 6 (16.7) | 0.0929 | 20 (25.6) |
|
| ||||
| Grade (%) | ||||
| High (3) | 21 (50.0) | 21 (58.3) | 0.4617 | 42 (53.8) |
| Low (1, 2) | 21 (50.0) | 15 (41.7) | 36 (46.2) | |
|
| ||||
| Hydronephrosis (%) | ||||
| (+) | 28 (66.7) | 26 (72.2) | 0.5961 | 54 (69.2) |
| (− ) | 14 (33.3) | 10 (27.8) | 24 (30.8) | |
|
| ||||
| CKD grade (%) | ||||
| ≤2 | 12 (28.6) | 17 (47.2) | 0.0893 | 29 (37.2) |
| ≥3 | 30 (71.4) | 19 (52.8) | 49 (62.8) | |
|
| ||||
| CRP (mg/dL) (%) | ||||
| <0.3 | 16 (38.1) | 12 (33.3) | 0.6621 | 28 (35.9) |
| ≥ 0.3 | 26 (61.9) | 24 (66.7) | 50 (64.1) | |
|
| ||||
| Type of surgery (%) | ||||
| Laparoscopic/robotic | 35 (83.3) | 31 (86.1) | 0.7346 | 66 (84.6) |
| Open | 7 (16.7) | 5 (13.9) | 12 (15.4) | |
ACT: adjuvant chemotherapy; CKD: chronic kidney disease; CRP C-reactive protein.